Income increased by 13 per cent to SEK 1,222 million (1,081). The operating surplus increased by 19 per cent to SEK 794 million (670). Profit from property management increased by 21 per cent to SEK 369 million (305). Changes in value of properties amounted to SEK 728 million (-114), of derivatives to SEK -319 million (317) and share of profits in associated companies amounted to SEK -56 million (7). Net profit amounted to SEK 671 million (440), corresponding to SEK 3.44 (2.09) per common share. Taking possession of 9 properties for SEK 4,080 million and sale of 7 properties for SEK 330 million. Globen City was taken possession of at the start of the second quarter. During the second quarter the business centre activities were launched under a separate brand name: First Office. Klövern now intends to also conceptualise its self storage operations under a separate brand name: Big Pink. Statement by the CEO Continued great interest in investing in the real estate market "The pace of activity continued to be high during the second quarter when the property portfolio expanded by around SEK 4 billion all at once through the acquisition of Globen City in early April. We also made a couple of smaller transactions during the quarter, including the acquisition of some properties in Kalmar and Gothenburg. Furthermore, Klövern signed its next biggest lease contract with the mobile phone operator Tele2 in Kista. Income during the quarter rose by 18 per cent, driven by acquisitions as well as an increased occupancy rate. Continued focus on costs contributed to costs only increasing at a moderate pace. As Globen City was taken possession of during the quarter, this has not yet had its full impact on earnings, although the operating surplus of SEK 426 million for the period is the highest that Klövern has ever had for a quarter by a good margin. The operating margin, the operating surplus as a proportion of income, increased to 67 per cent (65). Interest in investing in the real estate market is increasing more and more. With a repo rate of 0.25 per cent and a 5-year rate at historic lows, it can be difficult to find the yield that many investors require in other kinds of asset. We notice this increased interest in a number of ways, including several institutional investors participating in making offers. These investors can often accept a lower required yield on properties and thus a higher price. This leads to a general reduction in the required yields in the property market. We can also see this in the existing portfolio where required yields for certain properties are falling slightly leading to positive changes in value. Klövern's strategy is to operate in selected growth locations. At the places we choose, we shall be among the leading and dominating real estate owners at the location. We will accordingly continue to reinforce the portfolio by acquisitions, investments in the existing portfolio, or new production. We can make our administration more efficient by selling properties in peripheral locations and instead investing in acquiring properties that are close to our existing portfolio. During the quarter, we acquired four properties in Kalmar for SEK 100 million. The properties are fully let and the total lettable area of around 13,500 sq.m. consists of office, retail and warehouse space. Klövern has a strong position on the Kalmar market and it is gratifying to be able to add on some properties that can be managed within the existing organization. We also continued to work on concentrating the portfolio by selling our remaining properties in Kristianstad and Landskrona. During the quarter we launched our business centre activities under a separate brand name: First Office. By clarifying the breadth of our geographic presence - we have 54 business centres in 16 cities - and adding new services, we expect to attract tenants to an even greater extent. We now also intend to conceptualise our self storage operations under a new brand name: Big Pink. We currently have a handful of self storage units and intend to open more. The banks' willingness to lend remains strong. During the quarter, we have extended a number of larger loans and have been offered continued good margins. We also took the opportunity of making use of a strong market interest to invest in preference shares during the quarter. We issued over 1.5 million preference shares in two different issues. In terms of earnings, the second quarter was Klövern's strongest ever, which feels very satisfactory. I would like to take the opportunity of wishing all tenants, employees and investors a pleasant summer", says Klöverns CEO Rutger Arnhult. For further information, please contact: Rutger Arnhult, CEO, +46 70-458 24 70, rutger.arnhult@klovern.se Lars Norrby, IR, +46 76-777 38 00, lars.norrby@klovern.se Klövern is a real estate company committed to working closely with customers to offer them efficient premises in Swedish growth regions. As of 30 June 2014, the value of the properties totalled SEK 29 billion and the rental value on an annual basis was SEK 2.9 billion. Klövern is listed on Nasdaq OMX Stockholm Mid Cap. For further information, see www.klovern.se. Klövern AB (publ), Box 1024, SE-611 29 Nyköping, Sweden. Phone: +46 155-44 33 00, fax: +46 155-44 33 22, e-mail: info@klovern.se. This information is such that Klövern AB (publ) is obliged to disclose under the Securities Market Act and/or the Financial Instruments Trading Act. The information was made available for publication on 10 July 2014. [HUG#1820031]
Klövern AB (publ): Interim Report January - June 2014
Top 10 Most Recent News Articles
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue ReadingTop 5 Most Recently Viewed Articles
NKGen Biotech to Present Innovative Research at Global Congress
NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...
Continue Reading
Celebrating Case Managers: A Call to Action for 2025
Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...
Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims
Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...
Continue Reading
Entourage Health Announces Going-Private Arrangement Plan
Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...
Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review
A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...
Continue Reading